Practo raises $90 ( Rs 573-crore) million in series C funding

Published On 2015-08-07 05:21 GMT   |   Update On 2015-08-07 05:21 GMT

This successful round of Series-C funding by Practo led by Tencent will help the company to focus on expanding the product line, look for potential acquisitions, and increase its manpowerHealthcare platform Practo has recently attracted a $90 million in Series C funding investment by different investors, lead by Tencent, with participation from Sofina, Sequoia India, Google Capital,...

Login or Register to read the full article
This successful round of Series-C funding by Practo led by Tencent will help the company to focus on expanding the product line, look for potential acquisitions, and increase its manpower

Healthcare platform Practo has recently attracted a $90 million in Series C funding investment by different investors, lead by Tencent, with participation from Sofina, Sequoia India, Google Capital, Altimeter Capital, Matrix Partners, Sequoia Capital Global Equities and Yuri Milner. The money will be churned further for expanding the product capabilities, seeking potential acquisitions, and suiting the manpower requirement of the company in the due course of time.

In next 3-6 months, the company’s focus areas for expansion include medicine, wellness and fitness, globally. Practo today enjoys presence in 35 Indian cities and three countries, and is focused to increase its presence to over 100 Indian cities and 10 countries across South East Asia, Latin America, the Middle East and Eastern Europe. The focus area of operations is to expand business in the diagnostic market.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News